Complete Cure of Persistent Virus Infections by Antiviral siRNAs

Autor: Isabelle Pelletier, Aure Saulnier, Karine Labadie, Florence Colbère-Garapin
Přispěvatelé: Virus Entérotropes et Stratégies Antivirales, Institut Pasteur [Paris] (IP), Pasteur Institute (DVPI and PTR), and the Ministère (MENESR), Institut Pasteur [Paris]
Rok vydání: 2006
Předmět:
Small interfering RNA
Mutant
Virus Replication
medicine.disease_cause
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
RNA interference
Chlorocebus aethiops
MESH: RNA
Small Interfering

Drug Discovery
MESH: Animals
RNA
Small Interfering

0303 health sciences
poliovirus
enterovirus
Poliovirus
030302 biochemistry & molecular biology
antiviral
3. Good health
Titer
MESH: RNA
Viral

RNA
Viral

Molecular Medicine
RNA Interference
MESH: Poliovirus
MESH: Mutation
MESH: RNA Interference
interference
Biology
Transfection
Virus
Cell Line
posttranscriptional gene silencing
03 medical and health sciences
Genetics
medicine
Animals
Humans
Molecular Biology
030304 developmental biology
Pharmacology
persistent infection
MESH: Humans
MESH: Transfection
MESH: Virus Replication
Genetic Therapy
chronic infection
MESH: Cercopithecus aethiops
Virology
MESH: Cell Line
Chronic infection
RNAi
siRNA
Mutation
MESH: Poliomyelitis
Enterovirus
MESH: Gene Therapy
Poliomyelitis
Zdroj: Molecular Therapy
Molecular Therapy, 2006, 13 (1), pp.142-50. ⟨10.1016/j.ymthe.2005.07.697⟩
Molecular Therapy, Cell Press, 2006, 13 (1), pp.142-50. ⟨10.1016/j.ymthe.2005.07.697⟩
ISSN: 1525-0016
1525-0024
DOI: 10.1016/j.ymthe.2005.07.697
Popis: Small interfering RNAs (siRNAs) have been developed as antiviral agents for mammalian cells. The capacity of specific siRNAs to prevent virus infections has been demonstrated, and there is evidence that these new antiviral agents could have a partial therapeutic effect a few days after infection. We investigated the possibility of curing a persistent infection, several months after becoming established, using an in vitro model of persistent poliovirus (PV) infection in HEp-2 cells. Despite high virus titers and the presence of PV mutants, repeated treatment with a mixture of two siRNAs targeting both noncoding and coding regions, one of them in a highly conserved region, resulted in the complete cure of the majority of persistently infected cultures. No escape mutants emerged in treated cultures. The antiviral effect of specific siRNAs, consistent with a mechanism of RNA interference, correlated with a decrease in the amount of viral RNA, until its complete disappearance, resulting in cultures cured of virions and viral RNA.
Databáze: OpenAIRE